Annual Review of Cancer Biology

Papers
(The H4-Index of Annual Review of Cancer Biology is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Immune Cell Metabolism and Immuno-Oncology121
Distinct Essentiality of the Mitochondrial Respiratory Chain in Proliferating Cells In Vivo42
Advances in Therapies Targeting Inhibitory Checkpoint Receptors: TIGIT, LAG-3, and Beyond38
lncRNAs as Targetable Nodes of Oncogenic Networks Underlying Cancer Progression and Therapy Resistance36
YAP, TAZ, and Hippo-Dysregulating Fusion Proteins in Cancer36
Mitochondria, OXPHOS, and Cancer Progression: A Modular View32
Lessons from 3D Reconstruction of Cancer28
Natural and Engineered Cytokines as Cancer Therapeutics24
Allogeneic CAR T Cell Therapy for Cancer22
Therapeutic Discovery for Chromatin Complexes: Where Do We Stand?21
Beyond Mice and Men: Alternative Vertebrate and Invertebrate Models in Cancer Biology20
Road Map to Defeat Pancreatic Cancer18
They Contain Multitudes: The Diverse Roles of CD4+ T Cells in Cancer Immunity18
Cancer Cell Polarity and Extrusion16
Engineering Cancer with Next-Generation Genome Editing Tools16
Stalled CARs: Mechanisms of Resistance to CAR T Cell Therapies16
Cancer Dependency Map: Past and Present16
0.26344585418701